CYP2E1 and metabolic dysfunction-associated steatotic liver disease: The altered activity of Wnt/β-catenin-Cyp2e1 pathway associated with human rs2302685 and mouse Lrp6 haploinsufficiency might account for the increased susceptibility to NAFLD and the reduced response to silibinin treatment.